AbCellera Biologics(ABCL) - 2024 Q4 - Earnings Call Transcript

AbCellera Biologics (ABCL) Q4 2024 Earnings Call February 27, 2025 05:00 PM ET Company Participants Tryn Stimart - Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy OfficerDr. Carl Hansen - Chairman, Chief Executive Officer, and PresidentAndrew Booth - CFOSteve Dechert - AVPJacqueline Kisa - Equity Research AssociateMalcolm Hoffman - Senior BioPharma Equity Research Associate Conference Call Participants Stephen Willey - AnalystNone - Analyst Operator Good afternoon and welcome to ...